SCHEMBL6859708

SCHEMBL6859708

COC(=O)CN(Cc1ccc(Cl)cc1)C1CCN(C(=O)OC(C)(C)C)C1.COC(=O)CN(Cc1ccc(Cl)cc1)C1CCNC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1D1 P20393 2/20 0.55
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GPR119 Q8TDV5 3/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
STS P08842 2/20 0.40
USP30 Q70CQ3 2/20 0.39
MBTPS1 Q14703 1/20 0.39
AHCY P23526 1/20 0.38
SSTR4 P31391 1/20 0.38
HSD11B1 P28845 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
PGR P06401 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654274 0.92 NR1D1 (0.63) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL655030 0.86 NR1D1 (0.55) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL655062 0.84 MBTPS1 (0.49) MBTPS1SSTR4SLC6A2SLC6A4CYP2D6
SCHEMBL652795 0.83 NR1D1 (0.61) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL654162 0.83 NR1D1 (0.65) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL654296 0.82 NR1D1 (0.64) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL655286 0.81 NR1D1 (0.60) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL655013 0.79 NR1D1 (0.65) NR1D1MEN1KMT2AGPR119JAK2
SCHEMBL653150 0.78 SLC6A2 (0.45) NR1D1MBTPS1SLC6A2SLC6A4SLC6A3
SCHEMBL653650 0.78 NR1D1 (0.64) NR1D1MEN1KMT2AGPR119JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448566-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-08-25 EP disclosed
WO-2003045942-A2 CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-06-05 WO disclosed